1. CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients
   Sebastian Meller et al, 2016, Epigenetics CrossRef
2. Carnitine Palmitoyltransferase 1 Regulates Prostate Cancer Growth under Hypoxia
   Leslimar Rios-Colon et al, 2021, Cancers CrossRef
3. MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer
   A. Cannistraci et al, 2022, Oncogene CrossRef
4. Androgen-Dependent Prostate Cancer Cells Reprogram Their Metabolic Signature upon GLUT1 Upregulation by Manganese Superoxide Dismutase
   Isabel Quiros-Gonzalez et al, 2022, Antioxidants CrossRef
5. GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors
   John M. Ryniawec et al, 2022, Diagnostics CrossRef
6. AKT, a Key Transmitter of HIF-1α and AR Signaling Pathways, Has a Critical Role in the Apigetrin-Mediated Anti-Cancer Effects in Prostate Cancer Cells
   You-Kyung Lee et al, 2022, Biomedicines CrossRef
7. Importance of GLUT Transporters in Disease Diagnosis and Treatment
   Abdelrahman Ismail et al, 2022, IJMS CrossRef
8. SPHK/HIF-1α Signaling Pathway Has a Critical Role in Chrysin-Induced Anticancer Activity in Hypoxia-Induced PC-3 Cells
   Hengmin Han et al, 2022, Cells CrossRef